SEP 7, 2026 · JOURNAL ARTICLE
Sprayable hydrogel loaded with engineered fusion cellular vesicles for cancer recurrence suppression
Journal of Nanobiotechnology
Preclinical proof-of-concept in engineered cellular vesicles and mouse tumor models; no human data, no efficacy endpoint with confidence intervals or statistical comparison, and no toxicity data reported.
Study details
DesignPreclinical in vitro and mouse tumor model…
InterventionSprayable hydrogel loaded with fusion cellu…